This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
World Health Organisation, WHO Coronavirus (COVID 19) Dashboard, (Cited 2022Oct5) Available from: https://covid19.who.int/Available from:https://covid19.who.int/Search in Google Scholar
McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. AutoimmunRev. 2020;19(6):102537.McGonagleDSharifKO’ReganABridgewoodCThe role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease202019610253710.1016/j.autrev.2020.102537719500232251717Search in Google Scholar
Oldfield V, Dhillon S, Plosker GL. Tocilizumab.Drugs. 2009;69(5):609-632.OldfieldVDhillonSPloskerGLTocilizumab200969560963210.2165/00003495-200969050-0000719368420Search in Google Scholar
KewanT, Covut F, Al-Jaghbeer MJ, Rose L, Gopalakrishna KV,Akbik B. EClinMed. 2020;24:100418KewanTCovut FAl-JaghbeerMJRoseLGopalakrishnaKVAkbikB20202410041810.1016/j.eclinm.2020.100418730550532766537Search in Google Scholar
Pham T,Claudepierre P, Constantin A, Bandt M, Fautrel B, Gossec L et al. Tocilizumab: Therapy and safety management. Joint Bone Spine. 2010;77:3-100.PhamTClaudepierrePConstantinABandtMFautrelBGossecLet alTocilizumab: Therapy and safety management201077310010.1016/S1297-319X(10)70001-420610315Search in Google Scholar